Use of Clozapine in the Treatment-Resistant Schizoprenia

Oğuzhan Kütük

DOI: 10.5606/jebms.2020.75609

Issue: 2020, Volume 1 - Issue 1
1265 1062

Nutrition and Depression

Nagihan Yılmaz, Hatice Özyürek, Nazlı Çetin, Berzah Güneş, Oytun Erbaş

DOI: 10.5606/jebms.2021.75651

Issue: 2021, Volume 2 - Issue 2
591 692

Synaptic Vesicle Protein 2A: Basic Facts and Roles in Schizophrenia

Aylin Kayaaltı, Berzah Güneş, Oytun Erbaş

DOI: 10.5606/jebms.2021.75677

Issue: 2021, Volume 2 - Issue 3
1486 578

Neuregulin 1 and Its Roles in Schizophrenia: A Systematic Review

Dildar Savcı, Sultan Karadeniz, Oytun Erbaş

DOI: 10.5606/jebms.2021.75683

Issue: 2021, Volume 2 - Issue 3
778 695

Gluten and Casein: Their Roles in Psychiatric Disorders

Ayşegül Şimal Ulaş, Arzu Çakır, , Oytun Erbaş

DOI: 10.5606/jebms.2022.1003

Issue: 2022, Volume 3 - Issue 1
6921 1675

Understanding the Role of DISC1 in Psychiatric Disorders

Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1011

Issue: 2022, Volume 3 - Issue 1
1009 571

Association of NOS1AP Variants in Schizophrenia

Ayşenur Saygılı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1013

Issue: 2022, Volume 3 - Issue 1
974 567

Schizophrenia Susceptibility Genes

Beyza Nur Akı, Oytun Erbaş

DOI: 10.5606/jebms.2022.1027

Issue: 2022, Volume 3 - Issue
672 607

Is Alpha-Lipoic Acid Effective in the Treatment of Obesity?

Saadet Pilten Güzel, Mahmut Sasani, Oytun Erbaş

DOI: 10.5606/jebms.2022.1029

Issue: 2022, Volume 3 - Issue
732 624

The Metabolic Syndrome: A Cancer Risk Factor?

Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş

DOI: 10.5606/jebms.2023.1040

Issue: 2023, Volume 4 - Issue 1
611 563

An Overview of Antipsychotics: Mechanisms of Action

Öznur Demirci, İrem Adar, Oytun Erbaş

DOI: 10.5606/jebms.2023.1047

Issue: 2023, Volume 4 - Issue 1
2652 1085

The Influence of Socioeconomic Status on Pregnancy Characteristics and Type 2 Diabetes

Hilal Özgül, Orhan Sadık Kızılyalın, Oytun Erbaş

DOI: 10.5606/jebms.2023.1062

Issue: 2023, Volume 4 - Issue 3
304 289